| For: | Athithan L, Gulsin GS, McCann GP, Levelt E. Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date. World J Diabetes 2019; 10(10): 490-510 [PMID: 31641426 DOI: 10.4239/wjd.v10.i10.490] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v10/i10/490.htm |
| Number | Citing Articles |
| 1 |
Eric Wang, Biao Feng, Shali Chen, Subrata Chakrabarti, Filomena de Nigris. Differential epigenetic regulation of glucose-induced alteration of miR-9 in retinal and cardiac endothelial cells. PLOS One 2026; 21(5) doi: 10.1371/journal.pone.0349188
|
| 2 |
Ingrid M. Heyns, Garrett Davis, Raghu Ganugula, M. N. V. Ravi Kumar, Meenakshi Arora. Glucose-Responsive Microgel Comprising Conventional Insulin and Curcumin-Laden Nanoparticles: a Potential Combination for Diabetes Management. The AAPS Journal 2023; 25(4) doi: 10.1208/s12248-023-00839-w
|
| 3 |
Angelica Cersosimo, Nadia Salerno, Jolanda Sabatino, Alessandra Scatteia, Giandomenico Bisaccia, Salvatore De Rosa, Santo Dellegrottaglie, Chiara Bucciarelli-Ducci, Daniele Torella, Isabella Leo. Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance. Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02181-7
|
| 4 |
Joanna M. Bilak, Jian L. Yeo, Gaurav S. Gulsin, Anna-Marie Marsh, Manjit Sian, Abhishek Dattani, Sarah L. Ayton, Kelly S. Parke, Moira Bain, Wenjie Pang, Sherif Boulos, Tim G. St Pierre, Melanie J. Davies, Thomas Yates, Gerry P. McCann, Emer M. Brady. Impact of the Remission of Type 2 Diabetes on Cardiovascular Structure and Function, Exercise Capacity and Risk Profile: A Propensity Matched Analysis. Journal of Cardiovascular Development and Disease 2023; 10(5) doi: 10.3390/jcdd10050191
|
| 5 |
Xiao‐long Zhang, Gang Zhang, Ze‐hong Bai. miR‐34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin‐1. Cell Biology International 2021; 45(3) doi: 10.1002/cbin.11512
|
| 6 |
Ioan‐Alexandru Minciună, Olga Hilda Orășan, Iulia Minciună, Andrada‐Luciana Lazar, Adela Viviana Sitar‐Tăut, Monica Oltean, Raluca Tomoaia, Mihai Puiu, Dan‐Andrei Sitar‐Tăut, Dana Pop, Angela Cozma. Assessment of subclinical diabetic cardiomyopathy by speckle‐tracking imaging. European Journal of Clinical Investigation 2021; 51(4) doi: 10.1111/eci.13475
|
| 7 |
Zhaohui Jiang, Lingyun Fu, Yini Xu, Xiaoxia Hu, Hong Yang, Yanyan Zhang, Hong Luo, Shiquan Gan, Ling Tao, Guiyou Liang, Xiangchun Shen. Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-63498-3
|
| 8 |
Lin Wang, Yin Cai, Liguo Jian, Chi Wai Cheung, Liangqing Zhang, Zhengyuan Xia. Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy. Cardiovascular Diabetology 2021; 20(1) doi: 10.1186/s12933-020-01188-0
|
| 9 |
Moein Ala, Izat Mohammad Khawajah, Sima Shamshiri Khamene. BET inhibitors in cardiovascular diseases: from atherosclerosis to heart failure. Pharmacological Reports 2026; 78(2) doi: 10.1007/s43440-025-00816-4
|
| 10 |
Lorena Ciumărnean, Mircea Vasile Milaciu, Vasile Negrean, Olga Hilda Orășan, Stefan Cristian Vesa, Octavia Sălăgean, Silvina Iluţ, Sonia Irina Vlaicu. Cardiovascular Risk Factors and Physical Activity for the Prevention of Cardiovascular Diseases in the Elderly. International Journal of Environmental Research and Public Health 2021; 19(1) doi: 10.3390/ijerph19010207
|
| 11 |
Barry A Borlaug, Michael D Jensen, Dalane W Kitzman, Carolyn S P Lam, Masaru Obokata, Oliver J Rider. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovascular Research 2023; 118(18) doi: 10.1093/cvr/cvac120
|
| 12 |
J. A. Henry, I. Abdesselam, O. Deal, A. J. Lewis, J. Rayner, M. Bernard, A. Dutour, B. Gaborit, F. Kober, A. Soghomonian, B. Sgromo, J. Byrne, T. Bege, B. A. Borlaug, S. Neubauer, O. J. Rider. The effect of bariatric surgery type on cardiac reverse remodelling. International Journal of Obesity 2024; 48(6) doi: 10.1038/s41366-024-01474-x
|
| 13 |
Xiu Wang, Shi Jin, Weina Hu, Gaetano Santulli. A Role of Glucose Overload in Diabetic Cardiomyopathy in Nonhuman Primates. Journal of Diabetes Research 2021; 2021 doi: 10.1155/2021/9676754
|
| 14 |
Bhoomika Sherkhane, Gundu Chayanika, Anika Sood, Dharmendra Kumar Khatri, Shashi Bala Singh. Mitochondrial remodelling—a vicious cycle in diabetic complications. Molecular Biology Reports 2021; 48(5) doi: 10.1007/s11033-021-06408-8
|
| 15 |
Anastasia Nikolaidou, Ioannis Ventoulis, Georgios Karakoulidis, Vasileios Anastasiou, Stylianos Daios, Spyridon-Filippos Papadopoulos, Matthaios Didagelos, John Parissis, Theodoros Karamitsos, Kalliopi Kotsa, Antonios Ziakas, Vasileios Kamperidis. Hypoglycemic Drugs in Patients with Diabetes Mellitus and Heart Failure: A Narrative Review. Medicina 2024; 60(6) doi: 10.3390/medicina60060912
|
| 16 |
Yuxin Li, Zhang Zhang, Sen Li, Tingting Yu, Zhaoqi Jia. Therapeutic Effects of Traditional Chinese Medicine on Cardiovascular Diseases: the Central Role of Calcium Signaling. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.682273
|
| 17 |
Lamiaa A. Ahmed, Nesma A. Shiha, Amina S. Attia. Escitalopram Ameliorates Cardiomyopathy in Type 2 Diabetic Rats via Modulation of Receptor for Advanced Glycation End Products and Its Downstream Signaling Cascades. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.579206
|
| 18 |
Priyanka Mathur, Vibha Rani. Investigating microRNAs in diabetic cardiomyopathy as tools for early detection and therapeutics. Molecular and Cellular Biochemistry 2023; 478(2) doi: 10.1007/s11010-022-04473-6
|
| 19 |
Vera S. Ivanchenko, Alina A. Gagarina, Irina Ya. Goryanskaya, Olga V. Soldatova, Alexey V. Ushakov. PATHOGENIC MECHANISMS OF HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Complex Issues of Cardiovascular Diseases 2023; 12(4S) doi: 10.17802/2306-1278-2023-12-4S-162-172
|
| 20 |
Ewa Radzioch, Bartłomiej Dąbek, Marta Balcerczyk-Lis, Weronika Frąk, Piotr Fularski, Ewelina Młynarska, Jacek Rysz, Beata Franczyk. Diabetic Cardiomyopathy—From Basics through Diagnosis to Treatment. Biomedicines 2024; 12(4) doi: 10.3390/biomedicines12040765
|
| 21 |
Byoung-Geun Han, Jun Young Lee, Mi Ryung Kim, Hanwul Shin, Jae-Seok Kim, Jae-Won Yang, Jong Yeon Kim, Vincenzo Lionetti. Fluid overload is a determinant for cardiac structural and functional impairments in type 2 diabetes mellitus and chronic kidney disease stage 5 not undergoing dialysis. PLOS ONE 2020; 15(7) doi: 10.1371/journal.pone.0235640
|
| 22 |
珏 王. Advances in the Pathogenesis and Treatment of MCP-1 in Diabetic Complications. Advances in Clinical Medicine 2022; 12(11) doi: 10.12677/ACM.2022.12111563
|
| 23 |
Yu-Rui Jiao, Kai-Xuan Chen, Xiang Tang, Yu-Long Tang, Hai-Lin Yang, Yu-Long Yin, Chang-Jun Li. Exosomes derived from mesenchymal stem cells in diabetes and diabetic complications. Cell Death & Disease 2024; 15(4) doi: 10.1038/s41419-024-06659-w
|
| 24 |
Tin Gojevic, Felipe V. C. Machado, Youri Bekhuis, Guido Claessen, Veronique Cornelissen, Marieke De Craemer, Paul Dendale, Maarten Falter, Sara M. Ferreira, Lieven Herbots, Sarah Hoedemakers, Matthijs Michielsen, Mauricio Milani, Jan Verwerft, Dominique Hansen. Effects of exercise on cardiac structure and function in patients with type 2 diabetes: a narrative review of prospective imaging studies. The International Journal of Cardiovascular Imaging 2025; 41(10) doi: 10.1007/s10554-025-03457-z
|
| 25 |
James L. Januzzi, Javed Butler, Stefano Del Prato, Justin A. Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam, Gregory D. Lewis, Thomas H. Marwick, Julio Rosenstock, W.H. Wilson Tang, Faiez Zannad, Francesca Lawson, Riccardo Perfetti, Alessia Urbinati. Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy. American Heart Journal 2023; 256 doi: 10.1016/j.ahj.2022.11.003
|
| 26 |
Honglin Wang, Eric Zi Rui Wang, Biao Feng, Subrata Chakrabarti, Filomena de Nigris. CircRNA_012164/MicroRNA-9-5p axis mediates cardiac fibrosis in diabetic cardiomyopathy. PLOS ONE 2024; 19(7) doi: 10.1371/journal.pone.0302772
|
| 27 |
Sabine Kleissl-Muir, Bodil Rasmussen, Alice Owen, Caryn Zinn, Andrea Driscoll. Low Carbohydrate Diets for Diabetic Cardiomyopathy: A Hypothesis. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.865489
|
| 28 |
Xiaopan Chen, Chuan Yun, Hailong Zheng, Xu Chen, Qianfei Han, Hua Pan, Yang Wang, Jianghua Zhong. The protective effects of S14G-humanin (HNG) against streptozotocin (STZ)-induced cardiac dysfunction. Bioengineered 2021; 12(1) doi: 10.1080/21655979.2021.1964894
|
| 29 |
Lama A. Ammar, Mohamad I. Nahlawi, Nizar W. Shayya, Hilda E. Ghadieh, Nadim S. Azar, Frédéric Harb, Assaad A. Eid. Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes. Frontiers in Cardiovascular Medicine 2021; 7 doi: 10.3389/fcvm.2020.630917
|
| 30 |
Sabine Kleissl-Muir, Caryn Zinn, Bodil Rasmussen, Alice Owen, Andrea Driscoll. Low carbohydrate diet for diabetic cardiomyopathy: Protocol for a randomised controlled trial. Journal of Metabolic Health 2022; 5(1) doi: 10.4102/jir.v5i1.73
|
| 31 |
Joanna M. Bilak, Gaurav S. Gulsin, Gerry P. McCann. Cardiovascular and systemic determinants of exercise capacity in people with type 2 diabetes mellitus. Therapeutic Advances in Endocrinology and Metabolism 2021; 12 doi: 10.1177/2042018820980235
|
| 32 |
Chidhambara Priya Dharshini Kottaisamy, Divya S. Raj, V. Prasanth Kumar, Umamaheswari Sankaran. Experimental animal models for diabetes and its related complications—a review. Laboratory Animal Research 2021; 37(1) doi: 10.1186/s42826-021-00101-4
|
| 33 |
Leila Chodari, Sina Fatehfar, Mahan Ahmadi, Vajihe Ghorbanzadeh. The impact of diabetes on tight junctions in cardiomyopathy dysfunction. Journal of Diabetes & Metabolic Disorders 2024; 23(2) doi: 10.1007/s40200-024-01469-5
|
| 34 |
Abhishek Kumar, Narendra Chaulagain, Sonal Fande, Karthik Shankar, Sanket Goel. Carbon Nitride Nanocomposite-Based Electrochemiluminescence Biosensor Platform for In Vitro Detection of Diabetic Cardiomyopathy Markers. ACS Applied Nano Materials 2025; 8(38) doi: 10.1021/acsanm.5c03298
|
| 35 |
Alexander E. Berezin, Alexander A. Berezin. Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative Review. Diabetes Therapy 2020; 11(6) doi: 10.1007/s13300-020-00835-9
|
| 36 |
Ressin Varghese, C. George Priya Doss, Raju Suresh Kumar, Abdulrahman I. Almansour, Natarajan Arumugam, Thomas Efferth, Siva Ramamoorthy. Cardioprotective effects of phytopigments via multiple signaling pathways. Phytomedicine 2022; 95 doi: 10.1016/j.phymed.2021.153859
|
| 37 |
J. A. Henry, I. Abdesselam, O. Deal, A. J. Lewis, J. Rayner, M. Bernard, A. Dutour, B. Gaborit, F. Kober, A. Soghomonian, B. Sgromo, J. Byrne, T. Bege, S. Neubauer, B. A. Borlaug, O. J. Rider. Changes in epicardial and visceral adipose tissue depots following bariatric surgery and their effect on cardiac geometry. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1092777
|
| 38 |
Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, Beverly Xin Yi Yeap, Joseph M Pappachan. Diabetic heart disease: A clinical update. World Journal of Diabetes 2021; 12(4): 383-406 doi: 10.4239/wjd.v12.i4.383
|
| 39 |
Raúl Vivar, Renatto Anfossi, Claudio Humeres, Mabel Catalán, Christopher Reyes, Simone Cárdenas, Alejandra Contreras, Pablo Aránguiz, Fabiola González, Guillermo Diaz-Araya. FoxO1 is required for high glucose-dependent cardiac fibroblasts into myofibroblast phenoconversion. Cellular Signalling 2021; 83 doi: 10.1016/j.cellsig.2021.109978
|
| 40 |
Elia Smeir, Ulrich Kintscher, Anna Foryst-Ludwig. Adipose tissue–heart crosstalk as a novel target for treatment of cardiometabolic diseases. Current Opinion in Pharmacology 2021; 60 doi: 10.1016/j.coph.2021.07.017
|
| 41 |
Omonzejie E. Imaralu, Chandrakala Aluganti Narasimhulu, Pawan K. Singal, Dinender K. Singla. Role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in diabetic complications. Canadian Journal of Physiology and Pharmacology 2024; 102(01) doi: 10.1139/cjpp-2023-0223
|
| 42 |
Xiao-fei Geng, Wen-yu Shang, Zhong-wen Qi, Chi Zhang, Wen-xiu Li, Zhi-peng Yan, Xin-biao Fan, Jun-ping Zhang. The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosis. Journal of Diabetes and its Complications 2024; 38(10) doi: 10.1016/j.jdiacomp.2024.108848
|
| 43 |
Eric Wang, Shali Chen, Honglin Wang, Tori Chen, Subrata Chakrabarti. Non-coding RNA-mediated endothelial-to-mesenchymal transition in human diabetic cardiomyopathy, potential regulation by DNA methylation. Cardiovascular Diabetology 2023; 22(1) doi: 10.1186/s12933-023-02039-4
|
| 44 |
Shu Song, Yue Ding, Guo-liang Dai, Yue Zhang, Meng-ting Xu, Jie-ru Shen, Ting-ting Chen, Yun Chen, Guo-liang Meng. Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation. Acta Pharmacologica Sinica 2021; 42(2) doi: 10.1038/s41401-020-0490-7
|
| 45 |
Setareh Soltani, Kamran Mansouri, Shahram Parvaneh, Avnesh S. Thakor, Flemming Pociot, Reza Yarani. Diabetes complications and extracellular vesicle therapy. Reviews in Endocrine and Metabolic Disorders 2022; 23(3) doi: 10.1007/s11154-021-09680-y
|
| 46 |
Bhagyalakshmi Balakrishnan, Raghu Chandrashekar Hariharapura, Veena Nayak, Divyashree M. Somashekara. Hyperglycaemia to heart failure: molecular pathophysiology, clinical manifestations, and novel therapeutic targets for diabetic cardiomyopathy. Archives of Physiology and Biochemistry 2026; 132(3) doi: 10.1080/13813455.2025.2567336
|
| 47 |
Pengbo Sun, Yangyang Wang, Yipei Ding, Jingyi Luo, Jin Zhong, Naihan Xu, Yaou Zhang, Weidong Xie. Canagliflozin attenuates lipotoxicity in cardiomyocytes and protects diabetic mouse hearts by inhibiting the mTOR/HIF-1α pathway. iScience 2021; 24(6) doi: 10.1016/j.isci.2021.102521
|
| 48 |
Ahmed Diab, Carla Valenzuela Ripoll, Zhen Guo, Ali Javaheri. HDL Composition, Heart Failure, and Its Comorbidities. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.846990
|
| 49 |
Wenwen Zheng, Qianxian Qi, Jie Li, Chaojie He, Hongyan Fan. Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategies. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01917-z
|
| 50 |
Sabine Kleissl-Muir, Alice Owen, Bodil Rasmussen, Caryn Zinn, Andrea Driscoll. Effects of a low carbohydrate diet on heart failure symptoms and quality of life in patients with diabetic cardiomyopathy: A randomised controlled trial pilot study. Nutrition, Metabolism and Cardiovascular Diseases 2023; 33(12) doi: 10.1016/j.numecd.2023.08.015
|
| 51 |
Eva R. Meulendijks, Carolina Janssen-Telders, Elise L. Hulsman, Nick Lobe, Pietro Zappala, Marc M. Terpstra, Robin Wesselink, Tim A.C. de Vries, Rushd F. Al-Shama, Ruben N. van Veen, Steve M.M. de Castro, Claire E.E. de Vries, Leontien M.G. Nijland, R. Nils Planken, Sebastien P.J. Krul, Joris R. de Groot. The change of epicardial adipose tissue characteristics and vulnerability for atrial fibrillation upon drastic weight loss. Adipocyte 2024; 13(1) doi: 10.1080/21623945.2024.2395565
|
| 52 |
Huan Chen, Da Tran, Hsiu-Chiung Yang, Sven Nylander, Yochai Birnbaum, Yumei Ye. Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay. Cardiovascular Drugs and Therapy 2020; 34(4) doi: 10.1007/s10557-020-06978-y
|
| 53 |
Ramzi Ahmad Al-Horani, Saja Janaydeh, Bahaa Al-Trad, Mukhallad Mohammed Aljanabi, Riyadh Muhaidat. Acute Exercise Promptly Normalizes Myocardial Myosin Heavy-Chain Isoform mRNA Composition in Diabetic Rats: Implications for Diabetic Cardiomyopathy. Medicina 2023; 59(12) doi: 10.3390/medicina59122193
|
| 54 |
Lina Hult, David Kylhammar, Jan Engvall, Carl Johan Östgren, Fredrik Nyström, Peter Blomstrand, Kristofer Hedman. Pathological post-systolic shortening as a prognostic marker for major cardiovascular events in patients with type 2 diabetes. Echo Research & Practice 2025; 12(1) doi: 10.1186/s44156-025-00085-0
|
| 55 |
Yumei Ye, Yochai Birnbaum, Steven G. Widen, Zhaohui Zhang, Shipeng Zhu, Mandeep Bajaj, Huan Chen. Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy. Cardiovascular Drugs and Therapy 2020; 34(6) doi: 10.1007/s10557-020-07043-4
|
| 56 |
Joanna M Bilak, Uazman Alam, Christopher A Miller, Gerry P McCann, Jayanth R Arnold, Prathap Kanagala. Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis. Cardiac Failure Review 2022; 8 doi: 10.15420/cfr.2022.12
|
| 57 |
Idowu Sunday Oyeleye, Olajide Raymond Ojo, Adeyinka Samuel Ajeigbe, Ganiyu Oboh. Hesperidin and acarbose combination therapy modulates inflammatory cytokines and cardiomyopathy-related biomolecules in diabetic rats subjected to aerobic exercise. Comparative Clinical Pathology 2024; 33(6) doi: 10.1007/s00580-024-03611-4
|
| 58 |
Prabhnain Kaur, Ritu Dahiya, Mukesh Nandave, Kalicharan Sharma, Ramesh K. Goyal. Unveiling the crucial role of intercellular adhesion molecule‐1 in secondary diabetic complications. Cell Biochemistry and Function 2024; 42(4) doi: 10.1002/cbf.4037
|
| 59 |
Dariga Uaydinichna Akasheva, Tatyana Gennadyevna Utina, Olga Nikolaevna Dzhioeva, Oxana Mikhailovna Drapkina. Subclinical Left Ventricular Dysfunction over Seven-Year Follow-Up in Type 2 Diabetes Patients without Cardiovascular Diseases. Biomedicines 2024; 12(9) doi: 10.3390/biomedicines12092031
|
| 60 |
Emma McAlister, Melissa Kirkby, Juan Domínguez-Robles, Alejandro J. Paredes, Qonita Kurnia Anjani, Kurtis Moffatt, Lalitkumar K. Vora, Aaron R.J. Hutton, Peter E. McKenna, Eneko Larrañeta, Ryan F. Donnelly. The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis. Advanced Drug Delivery Reviews 2021; 175 doi: 10.1016/j.addr.2021.06.002
|
| 61 |
Hui‐Min Zhou, Yun Ti, Hui Wang, Yuan‐Yuan Shang, Ya‐Peng Liu, Xiao‐Ning Ni, Di Wang, Zhi‐Hao Wang, Wei Zhang, Ming Zhong. Cell death‐inducing DFFA‐like effector C/CIDEC gene silencing alleviates diabetic cardiomyopathy via upregulating AMPKa phosphorylation. The FASEB Journal 2021; 35(5) doi: 10.1096/fj.202002562R
|
| 62 |
Ernest A. Adeghate, Sahar Mohsin, Ahmed Bin Amar, Suhail AlAmry, Mariam AlOtaiba, Omobola Awosika Oyeleye, Jaipaul Singh. Etiology, Prevention and Management of Cardiomyopathy. Cardiology and Cardiovascular Medicine 2024; 6 doi: 10.5772/intechopen.1006679
|
| 63 |
Grace W. M. Walters, Emma Redman, Gaurav S. Gulsin, Joseph Henson, Stavroula Argyridou, Thomas Yates, Melanie J. Davies, Kelly Parke, Gerry P. McCann, Emer M. Brady. Interrelationship between micronutrients and cardiovascular structure and function in type 2 diabetes. Journal of Nutritional Science 2021; 10 doi: 10.1017/jns.2021.82
|
| 64 |
Branislav Kura, Lucia Kindernay, Dinender Singla, Ulrika Dulova, Monika Bartekova. Mechanistic insight into the role of cardiac-enriched microRNAs in diabetic heart injury. American Journal of Physiology-Heart and Circulatory Physiology 2025; 328(4) doi: 10.1152/ajpheart.00736.2024
|
| 65 |
Edgar Francisco Carrizales-Sepúlveda, Raymundo Vera-Pineda, Raúl Alberto Jiménez-Castillo, Jorge Rafael Violante-Cumpa, Ramiro Flores-Ramírez, Alejandro Ordaz-Farías. The Heart in Diabetic Ketoacidosis: A Narrative Review Focusing on the Acute Cardiac Effects and Electrocardiographic Abnormalities. The American Journal of the Medical Sciences 2021; 361(6) doi: 10.1016/j.amjms.2020.11.030
|
| 66 |
Xu Zhang, Pei-Xiong Ke, Xun Yuan, Gui-Ping Zhang, Wen-Liang Chen, Gen-Shui Zhang, Juan Carlos Corona. Forskolin Protected against Streptozotocin‐Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Cardiac Fibrosis in Mice. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/8881843
|
| 67 |
Natsuki Nakayama. Carnitine Deficiency and Insufficiency in Medicine. 2026; doi: 10.1007/978-981-95-7797-2_3
|
| 68 |
Natsuki Nakayama. Carnitine Deficiency and Insufficiency in Medicine. 2026; doi: 10.1007/978-981-95-7797-2_16
|
| 69 |
Paolo Severino, Andrea D'Amato, Mariateresa Pucci, Fabio Infusino, Francesco Adamo, Lucia Ilaria Birtolo, Lucrezia Netti, Giulio Montefusco, Cristina Chimenti, Carlo Lavalle, Viviana Maestrini, Massimo Mancone, William M. Chilian, Francesco Fedele. Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction. International Journal of Molecular Sciences 2020; 21(21) doi: 10.3390/ijms21218118
|